Arnold & Porter Kaye Scholer LLP
Compositions and methods for C. difficile treatment
The present disclosure provides compositions and methods for treating Clostridium difficile infection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.
Regents of the University of Minnesota
A A A A A A A A A A A A
A61K A61K A61K A61K A01N A61K A61K A61P A61K A61K A61K A61K
additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Christopher M. Matthew J. Michael J. Alexander
Staley Hamilton Sadowsky Khoruts